<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/geva" ></link>
<id>urn:uuid:b7a4d814-66f7-c340-c61a-ba73e898ed8a</id>
<updated>2013-05-18T21:31:11-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>GEVA: PATEL SANJ K (PR,CEO,DIR) Exercised 31,605 Options (OE) of SYNAGEVA BIOPHARMA CORP for $0.95 on 4/5-4/8, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/geva/synageva-biopharma-corp/id-2405735" ></link>
<id>urn:uuid:4d45bbc6-fad9-6562-fb91-9be9d6c31e6d</id>
<updated>2013-04-09T16:21:09-04:00</updated>
<summary type="html" ><![CDATA[SYNAGEVA BIOPHARMA CORP (GEVA). Recent Price: $39.87. Mkt Cap:1.1B. 10D Vol: 120k]]></summary>
</entry>
<entry>
<title>GEVA: PATEL SANJ K (PR,CEO,DIR) Exercised 38,395 Options (OE) of SYNAGEVA BIOPHARMA CORP for $0.95 on 4/3-4/4, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/geva/synageva-biopharma-corp/id-2404536" ></link>
<id>urn:uuid:bb53b4c6-8643-8787-6c0f-20940fbbef0f</id>
<updated>2013-04-05T14:21:10-04:00</updated>
<summary type="html" ><![CDATA[SYNAGEVA BIOPHARMA CORP (GEVA). Recent Price: $39.87. Mkt Cap:1.1B. 10D Vol: 120k]]></summary>
</entry>
<entry>
<title>GEVA: GOLDBERG MARK ALAN (VP,LO) Exercised 4,416 Options (OE) of SYNAGEVA BIOPHARMA CORP for $0.95 on 4/1, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/geva/synageva-biopharma-corp/id-2402104" ></link>
<id>urn:uuid:f5981796-63b7-7bbd-012d-e85295687484</id>
<updated>2013-04-03T10:21:09-04:00</updated>
<summary type="html" ><![CDATA[SYNAGEVA BIOPHARMA CORP (GEVA). Recent Price: $39.87. Mkt Cap:1.1B. 10D Vol: 120k]]></summary>
</entry>
<entry>
<title>GEVA: GOLDBERG MARK ALAN (VP) Exercised 4,417 Options (OE) of SYNAGEVA BIOPHARMA CORP for $0.95 on 3/1, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/geva/synageva-biopharma-corp/id-2379674" ></link>
<id>urn:uuid:a25b00a1-273f-f257-635a-9989e31023df</id>
<updated>2013-03-06T06:00:29-05:00</updated>
<summary type="html" ><![CDATA[SYNAGEVA BIOPHARMA CORP (GEVA). Recent Price: $39.87. Mkt Cap:1.1B. 10D Vol: 120k]]></summary>
</entry>
<entry>
<title>GEVA: PATEL SANJ K (PR,CEO,DIR) Exercised 70k Options (OE) of SYNAGEVA BIOPHARMA CORP for $0.95 on 2/20-2/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/geva/synageva-biopharma-corp/id-2366771" ></link>
<id>urn:uuid:1f86b38d-4401-bd3a-c955-2b76e68e079f</id>
<updated>2013-02-22T17:05:30-05:00</updated>
<summary type="html" ><![CDATA[SYNAGEVA BIOPHARMA CORP (GEVA). Recent Price: $39.87. Mkt Cap:1.1B. 10D Vol: 120k]]></summary>
</entry>
</feed>